4
Changes in Ownership
Kairos Pharma, LTD. Filed Acc 0001641172-25-002927
Chief Scientific Officer acquired 14,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bhowmick Neil Chief Scientific Officer | 2025-01-01 | Grant or award | +14,000 | 1,139,983 | D: show line 1 in the form |
Loading xslF345X05/ownership.xml…